Deprescripción de inhibidores de la bomba de protones en atención primaria
SAP Primary Care · 13.10.2026 · 2 · 172
DOI: 10.62486/pc2026172 ↗Kurz gefasst
Fachartikel in der Zeitschrift SAP Primary Care, online erschienen am 13.10.2026. Verfasst von Laura Beatriz Fernández Feitó und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction: proton pump inhibitors (PPIs) are among the most widely used drugs worldwide, and a considerable share of long-term prescriptions lacks a documented indication or periodic review, exposing patients to avoidable risks and burdening health systems. Objective: to critically describe the evidence on the extent of PPI overuse, the safety concerns associated with prolonged use, the rebound phenomenon after withdrawal and the deprescribing strategies applicable in primary care. Development: nearly one in four adults uses a PPI, and in primary care records most continuous users have no recorded indication. The evidence linking PPIs to adverse outcomes is mostly observational and of low certainty, while stopping a PPI can trigger transient acid-related symptoms. Interventions that combine a decision algorithm for the clinician with patient education and shared decision-making increase step-down or discontinuation; tapering or on-demand use suit mild disease, whereas complicated reflux disease, Barrett's esophagus, eosinophilic esophagitis and high gastrointestinal bleeding risk generally call for continuing therapy. Conclusions: deprescribing should be a periodic, individualized and shared process driven by the absence of an indication rather than by fear of adverse effects, and the primary care physician is well placed to lead it.
Zitieren
APA
Feitó, L. B. F., Llaugert, A. G., Claro, L. B. G., Ramírez, L. M., González, M. A. G., & Pazos, A. A. (2026). Deprescripción de inhibidores de la bomba de protones en atención primaria. SAP Primary Care, 2, 172. https://doi.org/10.62486/pc2026172
Vancouver
Feitó LBF, Llaugert AG, Claro LBG, Ramírez LM, González MAG, Pazos AA. Deprescripción de inhibidores de la bomba de protones en atención primaria. SAP Primary Care. 2026;2:172. doi:10.62486/pc2026172
BibTeX
@article{Feit2026,
author = {Feitó, Laura Beatriz Fernández and Llaugert, Andrea González and Claro, Lauren Beatriz González and Ramírez, Lauren Martínez and González, Mariam Alejandra González and Pazos, Andy Alonso},
title = {Deprescripción de inhibidores de la bomba de protones en atención primaria},
journal = {SAP Primary Care},
year = {2026},
volume = {2},
pages = {172},
doi = {10.62486/pc2026172}
}
EUVIMED